At baseline , each 1-SD increase in baseline PSQ score was associated with an adjusted odds ratio that was 3 to 4 times higher for behavioral morbidity , 2 times higher for reduced global quality of life , 6 times higher for reduced disease-specific quality of life , and 2 times higher for sleepiness .